Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FD5QA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,861
Award facts
- Contract value 100% obligated
- $6,860.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,860.50 by the Defense Logistics Agency (DLA) on September 23, 2025, for the supply of Nexplanon 68 mg implants. The contract, which carries no set-aside designation, is expected to be completed by October 15, 2025, with performance taking place at the vendor's Park Ridge, Illinois location. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities.
Nexplanon implants are subdermal contraceptive devices that represent one category within DMS Pharmaceutical Group's extensive portfolio of pharmaceutical deliveries to federal healthcare systems. The company has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in DLA procurement markets. Through the SPE2DB program vehicle, DMS Pharmaceutical Group provides direct distribution of prescription drugs, biologics, medical consumables, and specialty medications to military health facilities nationwide, making this relatively modest delivery order part of a larger strategic partnership supporting the Department of Defense's medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FD5QA?
SPE2DB25FD5QA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FD5QA worth?
The government has obligated $6,861 on SPE2DB25FD5QA.
Is contract SPE2DB25FD5QA an order under another contract?
Yes. SPE2DB25FD5QA is a delivery order under SPE2DB20D9759, an indefinite delivery contract.
Was contract SPE2DB25FD5QA competed?
The extent of competition for SPE2DB25FD5QA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award